Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis
- PMID: 32701581
- DOI: 10.1097/QAD.0000000000002593
Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis
Abstract
Objective: Assess adverse perinatal outcomes associated with antenatal antiretroviral therapy (ART) regimens.
Design: Systematic review and network meta-analysis of randomized controlled trials (RCTS).
Methods: We conducted a systematic literature review by searching PubMed, CINAHL, Global Health, EMBASE, and the Cochrane Central Register of Controlled Trials and four clinical trial databases from 1 January 1980 to 28 April 2018. We included RCTs of antenatal ART regimens in HIV-positive pregnant women, which assessed preterm birth (PTB), spontaneous preterm birth (sPTB), very preterm birth (VPTB), low birthweight (LBW), very low birthweight (VLBW), small-for-gestational-age (SGA), neonatal death (NND), and mother-to-child-transmission. We used random-effects network meta-analysis models to calculate relative risks for treatment comparisons and the hierarchy of treatments.
Results: Of 83 260 citations identified, 10 manuscripts were included, assessing 6285 women. Compared with zidovudine (ZDV) monotherapy, we found a higher risk of LBW after exposure to zidovudine/lamivudine/efavirenz (ZDV/3TC/EFV; relative risk 1.61; 95% CI 1.03-2.51), tenofovir disoproxil fumarate/emtricitabine/ritonavir-boosted lopinavir (TDF/FTC/LPV/r; 1.64; 1.18-2.29), or zidovudine/lamivudine/ritonavir-boosted lopinavir (ZDV/3TC/LPV/r; 1.87; 1.58-2.20). TDF/FTC/LPV/r carried an increased risk of VLBW, compared with ZDV monotherapy (5.40; 1.08-27.08). ZDV/3TC/LPV/r posed a higher risk of PTB than ZDV monotherapy (1.43; 1.08-1.91) and a higher risk of sPTB than zidovudine/lamivudine/abacavir (ZDV/3TC/ABC) (1.81; 1.21-2.71). LPV/r-containing regimens also carried the highest risks of VPTB, SGA and NND, although the limited data showed no significant differences.
Conclusion: Of the ART regimens assessed in RCTs in pregnancy, LPV/r-containing regimens were associated with the highest risks of adverse perinatal outcomes.
Similar articles
-
Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.N Engl J Med. 2018 Apr 26;378(17):1593-1603. doi: 10.1056/NEJMoa1701666. N Engl J Med. 2018. PMID: 29694825 Free PMC article.
-
Preterm delivery and small-for-gestation outcomes in HIV-infected pregnant women on antiretroviral therapy in rural South Africa: Results from a cohort study, 2010-2015.PLoS One. 2018 Feb 22;13(2):e0192805. doi: 10.1371/journal.pone.0192805. eCollection 2018. PLoS One. 2018. PMID: 29470508 Free PMC article.
-
Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.JAMA Pediatr. 2017 Oct 2;171(10):e172222. doi: 10.1001/jamapediatrics.2017.2222. Epub 2017 Oct 2. JAMA Pediatr. 2017. PMID: 28783807 Free PMC article.
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
Cited by
-
Comparison of safety and effectiveness of antiretroviral therapy regimens among pregnant women living with HIV at preconception or during pregnancy: a systematic review and network meta-analysis of randomized trials.BMC Infect Dis. 2024 Apr 19;24(1):417. doi: 10.1186/s12879-024-09303-2. BMC Infect Dis. 2024. PMID: 38641597 Free PMC article.
-
Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis.Front Med (Lausanne). 2024 Feb 27;11:1323813. doi: 10.3389/fmed.2024.1323813. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38476445 Free PMC article.
-
Time trends in perinatal outcomes among HIV-positive pregnant women in Northern Tanzania: A registry-based study.PLoS One. 2023 Aug 10;18(8):e0289740. doi: 10.1371/journal.pone.0289740. eCollection 2023. PLoS One. 2023. PMID: 37561712 Free PMC article.
-
Adverse perinatal outcomes attributable to HIV in sub-Saharan Africa from 1990 to 2020: Systematic review and meta-analyses.Commun Med (Lond). 2023 Jul 22;3(1):103. doi: 10.1038/s43856-023-00331-8. Commun Med (Lond). 2023. PMID: 37481594 Free PMC article.
-
Antenatal depression and adverse birth outcomes among pregnant women living with HIV in Dar es Salaam, Tanzania.J Affect Disord. 2023 Oct 15;339:82-88. doi: 10.1016/j.jad.2023.07.047. Epub 2023 Jul 10. J Affect Disord. 2023. PMID: 37437720 Clinical Trial.
References
-
- UNAIDS. Global AIDS Update. Geneva, Switzerland: UNAIDS; 2019.
-
- GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1725–1774.
-
- Wedi CO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV 2016; 3:e33–e48.
-
- Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016; 388:3027–3035.
-
- Lee AC, Kozuki N, Cousens S, Stevens GA, Blencowe H, Silveira MF, et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ 2017; 358:j3677.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous